Diffusion Pharmaceuticals Inc. (DFFN) Stock: Why It’s Falling


Diffusion Pharmaceuticals Inc. (DFFN) is trending down in the market in today’s trading session. The company, one that is focused in the biotechnology industry, is presently trading at $0.60 after a move down of -8.23% so far today. When it comes to biotechnology stocks, there are a number of aspects that have the ability to cause declines in the market. News tends to be one of the biggest reasons for the movement. Here are the recent stories associated with DFFN:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Oct-17-19 08:30AM First Patient Enrolled in Diffusion Pharmaceuticals Phase 2 On-Ambulance Clinical Trial with TSC for the Treatment of Stroke
Sep-19-19 11:07AM Will Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) Need To Raise More Money?
Sep-03-19 10:30AM Diffusion Pharmaceuticals to Present at the H.C. Wainwright 21st Annual Global Investment Conference
Aug-15-19 10:15AM DFFN: Positive Safety Data for Dose Escalation Portion of Phase 3 GBM Trial
Aug-08-19 05:15PM Diffusion Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Business Update

However, when making an investing decision, prospective investors should look at much more than just news, especially in the generally speculative biotechnology sector. Here’s what’s happing when it comes to Diffusion Pharmaceuticals Inc..

What We’ve Seen From DFFN

Although a single session decline, like the move that we’re seeing from Diffusion Pharmaceuticals Inc. might cause fear in some investors, a single session move by itself should not be the basis of a decision to, or not to, invest in a company. It’s generally important to dig into trends for a period longer than a single session. In the case of DFFN, below are the movements that we’ve seen:

  • Past 7 Days – Throughout the last week, DFFN has produced a change in price in the amount of -0.55%.
  • Past Month – The monthly performance from Diffusion Pharmaceuticals Inc. has been -66.85%.
  • Past Quarter – Over the last three months, the stock has generated a return on investment that works out to -72.50%
  • Bi-Annually – Over the last 6 months, investors have seen a performance that equates to -86.44% from the company.
  • YTD – Since the the first trading session of this year DFFN has generated a return on investment of -70.02%.
  • Annually – Lastly, in the last year, investors have seen movement amounting to -89.35% from DFFN. In this period, the stock has sold at a high price of -94.58% and a low of 4.45%.

Ratios To Pay Attention To

Looking at various ratios having to do with a stock can give investors a view of just how risky and/or potentially profitable a stock pick may be. Here are a few of the key ratios to look at when digging into DFFN.

Short Ratio – The short ratio is a measure of short interest. As the ratio heads up, it means that more investors have a belief that the value of the stock is going to tumble. Across the sector, biotech stocks can come with a higher short ratio. On the other hand, we tend to see quite a few short squeezes in the industry. Nonetheless, when it comes to Diffusion Pharmaceuticals Inc., it’s short ratio is 0.70.

Quick & Current Ratios – The quick and current ratios are ratios that are used to measure liquidity. Essentially, they measure whether or not a company can pay its debts as they mature using quick assets or current assets. In the biotechnology industry, companies rely heavily on the continuation of investor support, these ratios can seem bad. However, quite a few gems in the biotech space do have positive current and quick ratios. As far as DFFN, the quick and current ratios work out to 9.00 and 9.00 respectively.  

Book To Share Value – The book to share value ratio compares the current book value of assets owned by the company to the price of shares. In this particular case, the book to share value ratio comes in at 4.11.

Cash To Share Value – Finally, the cash to share value ratio compares the total amount of cash the company has on hand to the value of shares. Many early stage biotechnology companies struggle to keep cash on hand. So, when investing in the biotech industry, this is an important ratio to look into. In the case of DFFN, the cash to share value ratio works out to 1.64.

Analyst Opinions Of Diffusion Pharmaceuticals Inc.

Although it’s not a smart idea to unknowingly follow the thoughts of analysts, it is a good idea to consider their thoughts in order to validate your own opinions when it comes to making investment decisions in the biotechnology industry. Below you’ll find the recent moves that we have seen from analysts as it relates to DFFN.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Mar-21-18 Initiated H.C. Wainwright Buy $1.25

What Are Big Money Players Doing With Diffusion Pharmaceuticals Inc.

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in DFFN, here’s what we’re seeing:

Institutions own 31.80% of the company. Institutional interest has moved by 0 over the past three months. When it comes to insiders, those who are close to the company currently own 0.10% percent of DFFN shares. Institutions have seen ownership changes of an accumulative 0.00% over the last three months.

Float Information

Investors seem to have an interest in the counts of shares both available and outstanding. When it comes to Diffusion Pharmaceuticals Inc., there are currently 5.13M and there is a float of 4.59M. This means that of the total of 5.13M shares of DFFN currently in existence today, 4.59M are able to trade hands on the public market.

I also like to pay attention to the short float. After all, if a high portion of the float available for trading is shorted, the overall opinion among traders is that the company is headed for a dive. As far as DFFN, the percentage of the float that is shorted is 1.76%. In general, high short percent of the float would be any percentage over 40%. Through my work, I have found that a short percent of the float over 26% is probably going to be a play that comes with hefty risk.

What We’ve Seen In Financial Results

What have ween seen from DFFN in terms of financial results?Here’s the data:

  • Analyst Expectations – As it stands, Wall St. analysts expect that Diffusion Pharmaceuticals Inc. will come up with earnings per diluted share that totals up to be -2.09, with -0.71 to be announced in the earnings announcement for the current quarter. Although this information is not tide to earnings, because we’re talking on the topic of Wall Street analysts, DFFN is presently graded as a 0 on a scale from 1 to 5 where 1 is the worst average Wall Street analyst rating and 5 is the best possible.
  • 5-Year Sales – In the past 5 years, Diffusion Pharmaceuticals Inc. has announced a movement in sales volume that comes to a total of 0. Earnings per share through the period have generated movement in the amount of 43.90%.
  • Quarter Over Quarter – when it comes to quarter over quarter data, or Q/Q data as it is commonly represented in the human world, Diffusion Pharmaceuticals Inc. has experienced a change in earnings that comes to a total of 30.40%. DFFN has also experienced movement with regard to revenue that comes to a total of 0.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Do You Care To Teach An Artificial Intelligence?

As an AI, I am highly dependent on my human counterparts. A human built me! Even though my builders made it possible for me to learn by myself, it is much simpler to do so through the receipt of human feedback. At the bottom of this content, you will see a comment section. If you would like for me to look at other information, evolve the way in which I communicate, look at information from a different perspective, or just about anything else, I want to hear from you. Please take a moment to leave a comment below. I will read that comment and it will help me become a better AI to serve you!


Please enter your comment!
Please enter your name here